Shandong Qidu Pharma Group is located in Shandong province，China . At present, Qidu Pharma has more than 3,800 employees, it spans more than 43 hectares of factory area, and has a total of3 billion CNY in assets.
Qidu Pharma Co. Ltd.
Qidu Pharma Co. Ltd. is a comprehensive and research-based drug production enterprise which produces IV solutions, Oral preparations, APIs, etc.. Products include basic infusions, intravenous nutrition liquid, plasma substitutes, anti-infective agents, antitumor drugs, internal secretion regulators and so on. The company has been approved to manufacture more than 190 products. Qidu Pharma is committed to the research of IV solutions and pharmacy intravenous admixture technology. The company has a professional sales team and a technical support department, providing high-quality products and outstanding services to patients who need emergent treatment by cooperating closely with medical institutions.
Since creation 43 years ago and a restructuring in 1998, Qidu Pharma has been adhering to the adage of “people-oriented, science and technology invigorating the enterprise”, and following the business philosophy of “Honesty, Cooperation, Development”. The company exhibits the arry forward the “Pragmatic, Innovation, Beyond” spirit .
Qidu Pharma is the key high-tech enterprise of the China Torch Program, the Backbone Enterprise of National Biomedical Industry Base, the National Comprehensive New Drug Research, the Development Technology Platform and Demonstration Enterprise of Industrialization, the National Demonstration Enterprise of Integration of Industrialization and Informatization, the National Advanced Enterprise, the National Trustworthy Enterprise, the Center of National Technology, and the Provincial Civilized Unit.
The trademarks “Qidu” and “Qidu Pharma” are well-known in China. Trademarks “QiJie” and “DiNuoXin” are famous throughout Shandong province.
Qidu Pharma has passed the ISO9001 , ISO14001, ISO45001, ISO50001 and National Intellectual Property Management System Certification. We have set postdoctoral research stations and Taishan Scholars Pharmacy Specialist posts. The company is the Vice President Unit of China Chemical and Pharmaceutical Industry Association, and it is part of the Directory Membership Unit of China Pharmaceutical Packaging Association, the Directory Membership Unit of China Pharmaceutical Engineering Equipment Association, the Directory Membership Unit of China Pharmaceutical Enterprise Management Association, and the Chief Supervisor Unit of Shandong Pharmaceutical Industry Association.As one of the Top 100 Pharmaceutical Enterprises in China, Qidu brand has superb public praise in the country, quality products that have a good reputation within the industry and have been exported to East Asia, South Asia, Southeast Asia, South America, Western Europe, Africa and other regions.
Qingdao Precision Medical Technology Co., Ltd.
Established in June 2013, Qingdao Precision Medical Technology Co. Ltd. is a subsidiary of Qidu Pharma Group. It is located in Qingdao High-tech Industrial Development Zone, spans an area of 8.7 hectares and has a registered capital of 80 million CNY. It is collective enterprise of scientific research,production, and management of medical equipment..The subsidiary has a primary focus on developing high-end medical consumables, devices, pharmaceuticals and other high-tech medical products, specifically hemopurification products, disinfection products, and diagnostic reagents.
Precision is a national high-tech enterprise and a Qingdao high-tech zone innovative enterprise. The company has passed ISO9001, ISO14001 , ISO13485 and CE certification.
The company has two major production bases in Qingdao and Zibo City. The company has formed three product series including more than 20 varieties and 60 specifications. The annual output of hemodialysis concentrate is 8 million persons, 3 million sets of blood dialyzer and bloodline, 20 million bottles/package/barrel of medical disinfectant and disinfectant wipes. We can provide customers with “whole industry chain of hemodialysis products, one-stop service, information technology and management, package solutions”.
Shandong Ujoin Medical Technology Co., Ltd.
Shandong Ujoin Medical Technology Co., Ltd., founded in 2009, is a national high-tech enterprise which focuses on research, development and production of new pharmaceutical packaging materials and medical supplies. The company is a regular member of China Pharmaceutical Packaging Association (CNPPA), member of China Pharmaceutical Packaging Standardization Working Committee and one of Top 50 Innovative and High-growth Enterprises in Zibo City. It has certified for ISO9001 and ISO14001.
Ujoin Medical Pharmaceutical Packaging Industry Base, covering an area of 33 acres, has 100 thousand square meters of clean workshops and an annual sales revenue of 1 billion CNY. Its main products include packaging materials for IV solutions, aseptic packaging materials for APIs, integrated packaging materials for pharmaceuticals and instruments, and new packaging materials for biodegradable food and drug, etc. The annual output of non-PVC multilayer co-extrusion film for IV solutions is 30 million square meters and that of PP caps and PP ports is 2 billion sets. The multicolor printing technology has been introduced exclusively in China, and the product quality has reached the international advanced level.
In the future, Qidu Pharma Group will focus on the overall deployment of group’ s development strategic plan closely, adhere to the drive of deepening reform and innovation, strict management and connotation development, adhere to people-oriented, science and technology, speed up the transformation from “scale” to “quality’’ and “efficiency”, and continue to move forward towards the grand vision and goal of “Centennial Qidu, International Qidu”, and strive to make greater contributions to economic, social, and pharmaceutical development for China!
Qidu Pharma was established in Jun 1976.
The first infusion workshop were built in Apr 1977.
The glucose raw material workshop with an annual output of 1500 tons went into operation in May 1990.
Qidu Pharma obtained China GMP certificate.
Qidu Pharmaceutical established an international business department.
The annual output of injections is 1.5 billion bottles/bag.
The annual output of oral preparation is 5 billion tablets/pills.
Top 100 Chinese Pharmaceutical Companies
The annual output of injections is 1.8 billion bottles/bag.
The annual output of oral preparation is 10 billion tablets/pills.
TOP 100 International Pharmaceutical Companies
Most Promising Pharmaceutical Company
The annual output of injections is 3 billion bottles/bag.
The annual output of oral preparation is 10 billion tablets/pills.
Qidu Pharma Group is composed of five subsidiaries: Shandong Qidu Pharmaceutical Co. Ltd; Qingdao Precision Medical Technology Co. Ltd; Shandong Ujoin Medical Technology Co. Ltd; Zibo Qidu Pharmaceutical Trading Co. Ltd.; and Zibo Jingrui Packaging Co. Ltd.